Malignant neoplasm of breast
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Keratoderma, Palmoplantar
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We have examined two families with this type of palmoplantar keratoderma and localized the causative genetic defect to a 14 cM interval on chromosome 12q11-q13, a region known to contain the keratin type II gene cluster as well as the retinoic acid receptor gamma gene.
|
7531539 |
1994 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
We, firstly, examined primary NB tumor tissue for a correlation between endogenous RAR gamma expression and clinical stage of the tumor and secondly, the effects of exogenous over-expression of the RAR gamma gene on a human NB tumor cell line.
|
7630632 |
1995 |
Neuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We, firstly, examined primary NB tumor tissue for a correlation between endogenous RAR gamma expression and clinical stage of the tumor and secondly, the effects of exogenous over-expression of the RAR gamma gene on a human NB tumor cell line.
|
7630632 |
1995 |
Central neuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We, firstly, examined primary NB tumor tissue for a correlation between endogenous RAR gamma expression and clinical stage of the tumor and secondly, the effects of exogenous over-expression of the RAR gamma gene on a human NB tumor cell line.
|
7630632 |
1995 |
Childhood Neuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We, firstly, examined primary NB tumor tissue for a correlation between endogenous RAR gamma expression and clinical stage of the tumor and secondly, the effects of exogenous over-expression of the RAR gamma gene on a human NB tumor cell line.
|
7630632 |
1995 |
Gastrointestinal Carcinoid Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The authors' previous work highlighted the finding that retinoid-mediated GCT differentiation in vitro correlates with expression of the retinoic acid receptor-gamma.
|
8625166 |
1995 |
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
|
8603404 |
1996 |
Breast Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
|
8603404 |
1996 |
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells.
|
8649863 |
1996 |
Congenital musculoskeletal anomalies
|
0.300 |
Biomarker
|
group |
CTD_human |
Contribution of retinoic acid receptor gamma to retinoid-induced craniofacial and axial defects.
|
9142499 |
1997 |
Leukemogenesis
|
0.020 |
Biomarker
|
disease |
BEFREE |
These data suggest that RAR alpha is necessary for appropriate response of the RAR beta and RAR gamma genes to physiologic changes and deregulation of the RAR alpha in transgenic mice, which resulted in upregulation of RAR beta and RAR gamma, can be associated with lymphomagenesis.
|
9116296 |
1997 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.
|
11231454 |
2001 |
Intestinal metaplasia
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.
|
11231454 |
2001 |
Squamous cell carcinoma of the head and neck
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines.
|
11340568 |
2001 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
In addition, some genes were up-regulated, including matrix metalloproteinse 2(MMP-2), MMP-16(MT3-MMP), SKY, CD9 and semaphorin V. A number of genes were down-regulated, including neuroendocrine-dlg (NE-dlg), retinoic acid receptor gamma and tumor suppressor DCC colorectal.
|
12174360 |
2002 |
Pancreatic Neoplasm
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax.
|
12189556 |
2002 |
Prostatic Hyperplasia
|
0.010 |
Biomarker
|
disease |
LHGDN |
Immunohistochemical localization of the retinoic Acid receptors in human prostate.
|
12399530 |
2003 |
Teratocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
|
16788091 |
2006 |
leukemia
|
0.040 |
Biomarker
|
disease |
LHGDN |
A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia.
|
17252005 |
2007 |
Liver carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma.
|
20197465 |
2010 |
Cleft Palate
|
0.300 |
Biomarker
|
disease |
CTD_human |
Retinoic acid drives aryl hydrocarbon receptor expression and is instrumental to dioxin-induced toxicity during palate development.
|
21807577 |
2011 |
Cleft palate, isolated
|
0.300 |
Biomarker
|
disease |
CTD_human |
Retinoic acid drives aryl hydrocarbon receptor expression and is instrumental to dioxin-induced toxicity during palate development.
|
21807577 |
2011 |
Leukemia, Myelocytic, Acute
|
0.040 |
Biomarker
|
disease |
BEFREE |
A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
|
20935257 |
2011 |
Acute Promyelocytic Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
|
20935257 |
2011 |